<searchTitle>Government Owned Inventions Available for Licensing/Collaboration: Tixocortol for the Prevention or Treatment of SARS-CoV-2 and Other Coronaviruses; Federal Register Vol. 89, Issue </searchTitle>
<granuleClass>NOTICE</granuleClass>
<accessId>2024-24565</accessId>
<agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
<agency order="2">National Institutes of Health</agency>
<billingCode>4140-01-P</billingCode>
<frDocNumber>2024-24565</frDocNumber>
<action>Notice.</action>
<summary>The National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is giving notice of the licensing and collaboration opportunity for the inventions listed below, which are owned by an agency of the U.S. Government and are available for licensing in the U.S. to achieve expeditious commercialization of results of federally- funded research and development.</summary>
<contact>Inquiries related to this licensing/ collaboration opportunity should be directed to: Suna Gulay French, Ph.D., Technology Transfer Manager, NCI, Technology Transfer Center, Email: suna.gulay@nih.gov or Phone: 240-276-7424.</contact>
<tocSubject1>Licenses; Exemptions, Applications, Amendments etc.</tocSubject1>
<tocDoc>Government-Owned Inventions, </tocDoc>
<emailRef>suna.gulay@nih.gov</emailRef>